OEL Fastrac Catalog

Please note, this OEL/ADE monograph also applies to alternate CAS RNs 50925-79-6, 8001-95-4 and colestipol hydrochloride (CAS RN 37296-80-3). Colestipol is indicated for use in the reduction of cholesterol in the treatment of hyperlipidemias. It is used as an adjunctive therapy to diet for the reduction of elevated serum total and low-density lipoprotein cholesterol (LDL-C) in patients with primary hypercholesterolemia (a condition that features elevated LDL-C) who do not respond adequately to diet. Although colestipol is effective in all types of hypercholesterolemia, it is reported to be most appropriate in patients with Fredrickson's type II hyperlipoproteinemia. It also may be helpful in reducing elevated cholesterol in patients with combined hypercholesterolemia and hypertriglyceridemia; however, it is not formally indicated where hypertriglyceridemia is the abnormality of greatest concern.

Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

Why do you need this OEL Fastrac monograph?

OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:

• The numerical OEL and control band assignment needed to determine the level of required engineering controls and personal protective equipment
• A listing of all cited references utilized in the derivation of the OEL and ADE
• An expert review and discussion with respect to the critical endpoints of concern, the rationale for the choice of endpoints, and dose that is to be used in the derivation of the ADE (PDE), as required by the EMA's Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Benefits of OEL Fastrac monographs

• Fully documented. Over 20 pages in length, with calculations and cited references.
• Save time! Unsurpassed delivery with instant download.
• Save money. Similar documents cost 5-12 times as much.
• Stay current. Automatic notification of revisions.

How to order

To order an OEL/ADE monograph for Colestipol, just click the ADD TO CART button.

HBEL

If you're wondering about HBEL, we have something for you.